SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:oru-97696"
 

Search: onr:"swepub:oai:DiVA.org:oru-97696" > Association of blaV...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Sid Ahmed, Mazen,1970-Örebro universitet,Institutionen för naturvetenskap och teknik,Department of Laboratory Medicine and Pathology, Microbiology Division, Hamad Medical Corporation, Doha, Qatar,The Life Science Centre-Biology (author)

Association of blaVIM-2, blaPDC-35, blaOXA-10, blaOXA-488 and blaVEB-9 β-Lactamase Genes with Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam in Multidrug-Resistant Pseudomonas aeruginosa

  • Article/chapterEnglish2022

Publisher, publication year, extent ...

  • 2022-01-19
  • MDPI,2022
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:oru-97696
  • https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-97696URI
  • https://doi.org/10.3390/antibiotics11020130DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Funding agencies:Medical Research Centre at Hamad Medical Corporation, Doha, Qatar IRGC-0151-033Qatar National Research Fund (Qatar Foundation) NPRP grant NPRP12S-0219-190109
  • Ceftazidime-avibactam and ceftolozane-tazobactam are approved for the treatment of complicated Gram-negative bacterial infections including multidrug-resistant (MDR) Pseudomonas aeruginosa. Resistance to both agents has been reported, but the underlying mechanisms have not been fully explored. This study aimed to correlate β-lactamases with phenotypic resistance to ceftazidime-avibactam and/or ceftolozane-tazobactam in MDR-P. aeruginosa from Qatar. A total of 525 MDR-P. aeruginosa isolates were collected from clinical specimens between 2014 and 2017. Identification and antimicrobial susceptibility were performed by the BD PhoenixTM system and gradient MIC test strips. Of the 75 sequenced MDR isolates, 35 (47%) were considered as having difficult-to-treat resistance, and 42 were resistant to ceftazidime-avibactam (37, 49.3%), and/or ceftolozane-tazobactam (40, 53.3%). They belonged to 12 sequence types, with ST235 being predominant (38%). Most isolates (97.6%) carried one or more β-lactamase genes, with blaOXA-488 (19%) and blaVEB-9 (45.2%) being predominant. A strong association was detected between class B β-lactamase genes and both ceftazidime-avibactam and ceftolozane-tazobactam resistance, while class A genes were associated with ceftolozane-tazobactam resistance. Co-resistance to ceftazidime-avibactam and ceftolozane-tazobactam correlated with the presence of blaVEB-9, blaPDC-35, blaVIM-2, blaOXA-10 and blaOXA-488. MDR-P. aeruginosa isolates resistant to both combination drugs were associated with class B β-lactamases (blaVIM-2) and class D β-lactamases (blaOXA-10), while ceftolozane-tazobactam resistance was associated with class A (blaVEB-9), class C (blaVPDC-35), and class D β-lactamases (blaOXA-488).

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Khan, Faisal Ahmad,1986-Örebro universitet,Institutionen för naturvetenskap och teknik,The Life Science Centre-Biology(Swepub:oru)fdkn (author)
  • Hadi, Hamad AbdelCommunicable Diseases Center, Hamad Medical Corporation, Doha, Qatar; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar (author)
  • Skariah, SiniDepartment of Microbiology and Immunology, Weill Cornell Medicine-Qatar, Doha, Qatar (author)
  • Sultan, Ali A.Department of Microbiology and Immunology, Weill Cornell Medicine-Qatar, Doha, Qatar (author)
  • Salam, AbdulDepartment of Epidemiology and Biostatistics, King Fahad Specialist Hospital, Dammam, Saudi Arabia (author)
  • Al Khal, Abdul LatifCommunicable Diseases Center, Hamad Medical Corporation, Doha, Qatar; Division of Infectious Diseases, Department of Medicine, Hamad Medical Corporation, Doha, Qatar (author)
  • Söderquist, Bo,1955-Örebro universitet,Institutionen för medicinska vetenskaper(Swepub:oru)bost (author)
  • Ibrahim, Emad BashirDepartment of Laboratory Medicine and Pathology, Microbiology Division, Hamad Medical Corporation, Doha, Qatar; Department of Microbiology and Immunology, Weill Cornell Medicine-Qatar, Doha, Qatar (author)
  • Omrani, Ali S (author)
  • Jass, Jana,1963-Örebro universitet,Institutionen för naturvetenskap och teknik,The Life Science Centre-Biology(Swepub:oru)jjs (author)
  • Örebro universitetInstitutionen för naturvetenskap och teknik (creator_code:org_t)

Related titles

  • In:Antibiotics: MDPI11:22079-6382

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view